TSXV:XRTX - Post Discussion
Post by
NLMoose on Jan 25, 2022 9:59am
Looks like "FSD Pharma Syndrome" Is Here At XORTX
When XORTX was recently listed on the NASDAQ, their stock was as high as $6.00 to $7.00 a share.
Since then, their stock has fallen below $2.00 a share.
Obviously, XORTX didn't learn from HUGE's mistakes, and now they are becoming another FSD Pharma.
Keep it up, and XORTX will get delisted like FSD Pharma is about to face.
Be the first to comment on this post